Last Week's Portfolio Changes
We raised three price targets and made two ratings changes last week.
Shutterstock
Below is a recap of last week's portfolio updates. Click here to read the Weekly Roundup posted on Friday.
Initiations/Exits
None
Price Target Updates
AbbVie (ABBV) -- We increased our ABBV price target to $110 in our Alert here.
Salesforce (CRM) -- Increased our CRM price target to $200 in our Weekly Roundup.
Marvell Technology Group (MRVL) -- We increased our MRVL price target to $35 in our Weekly Roundup.
Ratings Changes
Goldman Sachs (GS) -- On Wednesday we downgraded our GS rating to Two here.
Nvidia (NVDA) -- On Wednesday we upgraded our NVDA rating to One here.
Action Alerts PLUS, which Cramer manages as a charitable trust, is long ABBV, CRM, MRVL, GS and NVDA.